Results 141 to 150 of about 12,265 (153)

<p>Therapeutic Potential of the Ranibizumab Port Delivery System in the Treatment of AMD: Evidence to Date</p>

Clinical Ophthalmology, 2020
Peter Kaiser, Eric R Chen
exaly  

Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye

Eye, 2011
Nicola Ghazi
exaly  

Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab

Eye, 2011
Carsten H Meyer, Holz F G
exaly  

Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo

Experimental Eye Research, 2007
Mauricio Maia, Jihong Yang, Valerie Quarmby   +2 more
exaly  

Ranibizumab

Reactions Weekly
openaire   +2 more sources

Pharmacokinetics of Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration: A Population Approach

2013
Tong Lu, Lisa A Damico-Beyer, Lisa Tuomi   +2 more
exaly  

Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab

Graefe's Archive for Clinical and Experimental Ophthalmology, 2015
Yanrong Jiang, Ying Zhou, Yujing Bai
exaly  

Ranibizumab

Reactions Weekly, 2009
openaire   +2 more sources

Ranibizumab

Reactions Weekly, 2008
openaire   +1 more source

Comparison of Bevacizumab, Ranibizumab, and Pegaptanib In Vitro: Efficiency and Possible Additional Pathways

2008
Alexa Klettner
exaly